Inpatient management of type 2 diabetes mellitus: Does choice of insulin regimen really matter?

Pakistan Journal of Medical Sciences

Volumn 30, Issue 4, 2014, Pages

  Akhtar, Syed Tehseen ^a   Mahmood, Khalid ^a   Naqvi, Iftikhar Haider ^a   Vaswani, Aneel Sham ^a  

^a DOW UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

Author keywords

Insulin regimen; Non critically ill type 2 diabetic patients

Indexed keywords

INSULIN; SHORT ACTING INSULIN;

ADULT; ARTICLE; BEDTIME DOSAGE; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE DURATION; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG DOSE TITRATION; FEMALE; GLYCEMIC CONTROL; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; TREATMENT DURATION;

EID: 84902952260     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: 10.12669/pjms.304.4920     Document Type: Article

References (21)

1. Baldwin D, Villanueva G, McNutt R, Bhatnagar S. Eliminating inpatient sliding scale insulin. Diabetes Care. 2005;28:1008-1011. DOI: 10.2337/diacare.28.5.1008
2. Clement S, Braithwaite SS, Magee MF, Ahmann A, Smith EP, Schafer RG, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27:553-591. DOI: 10.2337/diacare.27.2.553
3. Garber AJ, Moghissi ES, Bransome ED, Clark NG, Clement S, Cobin RH, et al. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract. 2004;10(Suppl. 2):4-9. DOI: 10.4158/EP.10.S2.4
4. Joslin EP: A Diabetic Manual for the Mutual Use of Doctor and Patient. Philadelphia, Lea & Febiger, 1934:108.
5. Queale WS, Seidler AJ, Brancati FL. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Intern Med 1997;157:545-552. DOI: 10.1001/archinte.1997.00440260101014
6. Gearhart JG, Duncan JL 3rd, Replogle WH, Forbes RC, Walley EJ. Effcacy of sliding-scale insulin therapy: a comparison with prospective regimens. Fam Pract Res J 1994;14:313-322.
7. Sawin CT: Action without beneft: the sliding scale of insulin use. Arch Intern Med. 1997;157:489. DOI: 10.1001/ archinte.1997.00440260019004
8. American Diabetes Association: Standards of medical care in diabetes (Position Statement). Diabetes Care. 2013;36(Suppl. 1):S11- S66.
9. Knecht LAD, Gauthier SM, Castro JC, Schmidt RE, Whitaker MD, Zimmerman RS, et al. Diabetes care in the hospital: is there clinical inertia? J Hosp Med. 2006;1:151-160. DOI: 10.1002/jhm.94
10. Schnipper JL, Barsky EE, Shaykevich S, Fitzmaurice G, Pendergrass ML: Inpatient management of diabetes and hyperglycemia among general medicine patients at a large teaching hospital. J Hosp Med. 2006;1:145-150. DOI: 10.1002/jhm.96
11. Cecilia LM, Guilleermo EU. Management of inpatient hyperglycemia in non critically ill patients. Diabetes Spectrum. 2008;21:4, 249-55.
12. Rubin DJ, Rybin D, Doros G, McDonnel ME. Weight-Based, Insulin Dose-Related Hypoglycemia in Hospitalized Patients with Diabetes. Diabetes Care. 2011;34:1723-1728. DOI: 10.2337/dc10-2434
13. Dickerson LM, Ye X, Sack JL, Hueston WJ. Glycemic control in medical inpatients with type 2 diabetes mellitus receiving sliding scale insulin regimens versus routine diabetes medications: a multicenter randomized controlled trial. Ann Fam Med 2003; 1:29-35. DOI: 10.1370/afm.2
14. Smith WD, Winterstein AG, Johns T, Rosenberg E, Sauer BC. Causes of hyperglycemia and hypoglycemia in adult inpatients. Am J Health Syst Pharm. 2005;62:714-719.
15. Umpierrez GE, Smiley D, Zisman A, Prieto LM, Palacio A, Ceron M, et al. Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients with Type 2 Diabetes (RABBIT 2 Trial). Diabetes Care. 2007;30:2181-2186. DOI: 10.2337/dc07-0295
16. Hor T, Smiley D, Munoz C, Temponi A, Umpierrez D, Ceron M, et al. Comparison of inpatient insulin regimens: detemir plus aspart vs. NPH plus regular in medical patients with type 2 diabetes (DEAN Trial) [Abstract]. Diabetes. 2008;57(Suppl. 1):458A.
17. Umpierrez GE, Jacobs DSS, Peng L, Temponi A, Mulligan P, Umpierrez D, et al. Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery) Diabetes Care 2011;34:256-261. DOI: 10.2337/dc10-1407
18. Moghissi ES, Korytkowski MT, Dinardo M. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on in-patient glycemic control. Diabetes Care. 2009;32:1119-1131. DOI: 10.2337/dc09-9029
19. King AB, Armstrong DU. Basal bolus dosing: a clinical experience. Curr Diabetes Rev. 2005;1:215-222. DOI: 10.2174/1573399054022794
20. Fritsche A, Larbig M, Owens D, Häring HU. Comparison between a basal-bolus and a premixed insulin regimen in individuals with type 2 diabetes-results of the GINGER study. Diabetes Obes Metab. 2010;12(2):115-123. DOI: 10.1111/j.1463-1326.2009.01165.x
21. Martin J. Anne Peters. Intensifcation of insulin therapy in patients with type 2 diabetes mellitus: An algorithm for basal-bolus therapy. Ann Med. 2012;44(8):836-846. DOI: 10.3109/07853890.2012.699715